共 90 条
[1]
Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin. 65 87-108
[2]
Bray F(2006)Epidemiology of gastric cancer World J Gastroenterol. 12 354-362
[3]
Siegel RL(2008)Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents? Oncologist. 13 794-806
[4]
Ferlay J(2008)Capecitabine and oxaliplatin for advanced esophagogastric cancer N Engl J Med. 358 36-46
[5]
Lortet-Tieulent J(2013)Current questions for the treatment of advanced gastric cancer Cancer Treat Rev. 39 60-67
[6]
Jemal A(2005)Gastric cancer: new genetic developments J Surg Oncol. 90 114-133
[7]
Crew KD(1965)The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification Acta Pathol Microbiol Scand. 64 31-49
[8]
Neugut AI(2014)Comprehensive molecular characterization of gastric adenocarcinoma Nature. 513 202-209
[9]
Pozzo C(2014)Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer Nat Genet. 46 573-582
[10]
Barone C(2014)Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma Nat Genet. 46 583-587